Rocket Mortgage Named #1 for Client Satisfaction in Mortgage Servicing by J.D. Power for the 11th Time
AI-powered servicing earns Rocket Mortgage top marks in overall satisfaction, ease, care and digital experience DETROIT, July 24, 2025 /PRNewswire/ — Rocket... Read more.
Nuvei Adds PINless Debit and Least Cost Routing to Boost Approval Rates in North America
Enhancements across its Authorization Optimization Suite improve authorization rates by up to 3.5 percentage points, helping merchants recover lost revenue and accelerate... Read more.
eSelf and Abarbanel University unveil the world’s first-ever AI Jewish Studies instructor to train the next generation of devoted leaders
TEL AVIV, Israel, July 24, 2025 /PRNewswire/ — eSelf, a global leader in creating face-to-face, natural-feeling conversational AI agents, announced a new... Read more.
SquareX Appoints Enterprise Sales Leader Steve Mullett as Vice President of Sales & GTM to Accelerate Market Growth and Expansion
PALO ALTO, Calif., July 24, 2025 /PRNewswire/ — SquareX, the leading browser security company, is proud to announce the appointment of Steve Mullett as Vice... Read more.
SHOPLINE & XRC Ventures Announce Brand Builder Grant Winners
Eight early-stage CPG startups will receive up to $50,000 to grow, scale, and upgrade their e-commerce platforms LOS ANGELES, July 24, 2025 /PRNewswire/ — Today... Read more.
Four New Leica SL3-S Kits: Attractive Centennial Offers from Leica Camera AG for First-Time Leica SL-System Users
TEANECK, N.J., July 24, 2025 /PRNewswire/ — This year, Leica Camera AG is celebrating the 100th anniversary of the first series-produced Leica camera. To... Read more.
ORCA Marine Brings Two Groundbreaking Sustainable Boating Solutions to the U.S. Market
Finsulate® and Hy.G Motors Set to Revolutionize Eco-Friendly Boating Across the U.S. and Canada YARMOUTH, Maine, July 24, 2025 /PRNewswire/ — ORCA Marine... Read more.
Pierre Fabre Pharmaceuticals Inc. Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Tabelecleucel for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
First allogeneic T-Cell therapy BLA offers hope to EBV+ PTLD patients who have limited treatment options and lifespan measured in only a few weeks to months following... Read more.
Greenlight Guru Acquires Enzyme to Power Ongoing Innovation and Strengthen Customer Support
Move marks the second acquisition in recent weeks, accelerating innovation for medtech and life sciences companies INDIANAPOLIS, July 24, 2025 /PRNewswire/ — Greenlight... Read more.
NYSE Content Advisory: Pre-Market update + McGraw Hill, Accelerant IPO on NYSE
NEW YORK, July 24, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s... Read more.